• 8163
    Citations - based on content available in repository [source: Scopus]
20042023

Content available in repository

Personal profile

Quote

My overarching goal is to institutionalize nanotechnologies for precision immunotherapy and immuno-imaging. In addition to making such precision medicine approaches available to patients, I strive to cultivate a unique research environment for the next generation of biomedical engineers.   

Research profile

Willem Mulder is a professor of Precision Medicine at both Radboudumc / Radboud University and the TU/e Department of Biomedical Engineering. His research focuses on precision immunotherapy and innovative molecular imaging approaches.

He develops nanotechnology for immunotherapy against cancer, inflammation, infectious and cardiovascular diseases, as well as to manage organ transplantation. Through the exploration of biological, chemical, and experimental knowledge, Mulder and his teams interconnect nanotechnology, imaging, and immunology with the overarching goal of developing nanomedicine strategies for detrimental immune-mediated diseases.

Academic background

Willem Mulder obtained an MSc in Chemistry from Utrecht University (the Netherlands) in 2001 and a PhD in Biomedical Engineering from Eindhoven University of Technology (TU/e, the Netherlands) in 2006. Thereafter, he was recruited to the Icahn School of Medicine at Mount Sinai  (New York, USA) where he founded the Nanomedicine Laboratory.

After a 15-year tenure at Mount Sinai, he returned to the Netherlands at the beginning of 2021 to establish a unique multidisciplinary research group spanning both the Radboud University Medical Center and the Eindhoven University of Technology. Participating in and driving innovative science today, allows young scientists from diverse backgrounds to flourish and mature into the engineers, scientists, and medical doctors of tomorrow.

Willem Mulder is co-founder and CSO of Trained Therapeutix Discovery, a scale-up biotech company developing nanobiologic immunotherapeutics. He also is the initiator, co-founder, and CTO of BioTrip, an entrepreneurial engine that is focused on developing innovative immunotherapies.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Dive into the research topics where Willem J.M. Mulder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Checkpoint NANO

    Mulder, Willem J.M. (Recipient), Nov 2018

    Prize: ERCConsolidatorScientific